Moderna, Inc. (MRNA) — Financial statements
Income statement, balance sheet, and cash flow for Moderna, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,944↓39.2% | 3,199↓53.3% | 6,848↓63.7% | 18,875↑6.4% | 17,736 | |
| Cost of Revenue | 868↓40.7% | 1,464↓68.8% | 4,693↓13.3% | 5,416↑107.0% | 2,617 | |
| Gross Profit | 1,076↓38.0% | 1,735↓19.5% | 2,155↓84.0% | 13,459↓11.0% | 15,119 | |
| Operating Expenses | ||||||
| R&D Expenses | 3,132↓31.1% | 4,543↓6.2% | 4,845↑47.0% | 3,295↑65.5% | 1,991 | |
| General & Administrative Expenses | 0.00↓100.0% | 1,028↓23.6% | 1,345↑33.0% | 1,011 | 0.00 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 146↓28.4% | 204↑68.6% | 121 | 0.00 | |
| SG&A Expenses | 1,018↓13.3% | 1,174↓24.2% | 1,549↑36.8% | 1,132↑99.6% | 567 | |
| Other Expenses | 0.00↑100.0% | -37 | 0.00↑100.0% | -388↑47.2% | -735 | |
| Operating Expenses | 4,150↓26.9% | 5,680↓11.2% | 6,394↑58.3% | 4,039↑121.6% | 1,823 | |
| Total Costs & Expenses | 5,018↓29.8% | 7,144↓35.6% | 11,087↑17.3% | 9,455↑113.0% | 4,440 | |
| Operating Results | ||||||
| Operating Income | -3,074↑22.1% | -3,945↑6.9% | -4,239↓145.0% | 9,420↓29.2% | 13,296 | |
| Depreciation & Amortization | 215↑13.8% | 189↓69.6% | 621↑78.4% | 348↑50.0% | 232 | |
| EBITDA | -2,553↑24.8% | -3,394↓3.4% | -3,283↓133.6% | 9,768↓27.8% | 13,528 | |
| EBIT | -2,768↑22.7% | -3,583↑8.2% | -3,904↓141.4% | 9,420↓29.2% | 13,296 | |
| Interest & Other Income | ||||||
| Net Interest Income | 314↓21.7% | 401↑4.7% | 383↑124.0% | 171 | 0.00 | |
| Interest Income | 314↓26.1% | 425↑1.0% | 421↑110.5% | 200↑1011.1% | 18 | |
| Interest Expense | 0.00↓100.0% | 24↓36.8% | 38↑31.0% | 29↑61.1% | 18 | |
| Non-Operating Income | -306↑15.5% | -362↓8.1% | -335 | 0.00 | 0.00 | |
| Other Income / Expenses | 306↓9.5% | 338↑13.8% | 297↑91.6% | 155↑1509.1% | -11 | |
| Income Before Tax | -2,768↑23.3% | -3,607↑8.5% | -3,942↓141.2% | 9,575↓27.9% | 13,285 | |
| Income Tax Expense | 54↑217.4% | -46↓106.0% | 772↓36.4% | 1,213↑12.0% | 1,083 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -2,822↑20.8% | -3,561↑24.5% | -4,714↓156.4% | 8,362↓31.5% | 12,202 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -2,822↑20.8% | -3,561↑24.5% | -4,714↓156.4% | 8,362↓31.5% | 12,202 | |
| Bottom-Line Net Income | -2,822↑20.8% | -3,561↑24.5% | -4,714↓156.4% | 8,362↓31.5% | 12,202 | |
| EPS (Basic) | -7.26↑21.7% | -9.27↑24.9% | -12.34↓158.0% | 21.26↓29.9% | 30.31 | |
| EPS (Diluted) | -7.26↑21.7% | -9.27↑24.9% | -12.34↓161.4% | 20.10↓29.0% | 28.29 | |
| Weighted Average Shares | 389↑1.3% | 384↑0.5% | 382↓3.0% | 394↓2.2% | 403 | |
| Weighted Average Diluted Shares | 389↑1.3% | 384↑0.5% | 382↓8.2% | 416↓3.5% | 431 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.